|1.||Holers, V Michael: 9 articles (01/2014 - 10/2002)|
|2.||Yan, Jun: 7 articles (11/2010 - 12/2003)|
|3.||Hansen, Richard: 6 articles (11/2010 - 08/2006)|
|4.||Edwards, Jennifer L: 5 articles (06/2011 - 09/2002)|
|5.||Das, Nibhriti: 5 articles (04/2007 - 04/2004)|
|6.||Stoute, José A: 4 articles (01/2015 - 01/2005)|
|7.||Erdei, Anna: 4 articles (01/2013 - 10/2004)|
|8.||Li, Bing: 4 articles (11/2010 - 08/2006)|
|9.||Quigg, Richard J: 4 articles (09/2010 - 09/2002)|
|10.||Arora, Vaishali: 4 articles (03/2007 - 04/2004)|
10/01/2010 - "Southeast Asian ovalocytosis (SAO), α(+)-thalassemia, and low expression of complement receptor 1 (CR1) have been associated with protection against severe Plasmodium falciparum malaria. "
11/01/2010 - "Some of the mechanisms underlying protection against this disease are described in this review for hemoglobin-inherited disorders (thalassemia, sickle-cell trait, HbC and HbE), erythrocyte polymorphisms (ovalocytosis and Duffy blood group), enzymopathies (G6PD deficiency and PK deficiency) and immunogenetic variants (HLA alleles, complement receptor 1, NOS2, tumor necrosis factor-α promoter and chromosome 5q31-q33 polymorphisms)."
04/01/2002 - "C3-/- mice showed delayed viral clearance and increased viral titers in lung, whereas mice deficient for complement receptors CR1 and CR2 (Cr2-/- mice) cleared the infection normally. "
01/01/2015 - "This study aimed to determine whether the ratio of the level of erythrocyte-bound C4d to that of complement receptor 1 (C4d/CR1) can serve as a useful biomarker in the differentiation between infection and flare-up in febrile SLE patients. "
01/01/1999 - "The present study was performed to investigate the role of CR3, the type 3 complement receptor, in host defense against primary and secondary Corynebacterium (C.) pseudotuberculosis infection in mice. "
01/01/2015 - "Interaction between gp350/220 and complement receptor type 2 (CR2)/CD21 and/or (CR1)/CD35 on B-cells is required for infection. "
11/01/2014 - "This modulation of TLR8 signaling was mediated by complement receptor 3 and led to enhanced infection. "
|3.||Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/01/2004 - "The present study investigated the expression of the complement receptor type 1 (CR1) on the membrane of erythrocytes (CR1/E) of patients with systemic lupus erythematosus (SLE) by flow cytometry. "
09/01/2002 - "This conceptual model is substantiated by studies indicating that complement receptor genes are within major susceptibility loci of systemic lupus erythematosus, that functional and structural abnormalities in these receptors are found in lupus mouse models, and that genetic polymorphism of lectin pathway genes correlates with increased risk of disease development. "
02/01/2014 - "Immune responses mediated by complement receptors (CR) are impaired in patients with systemic lupus erythematosus (SLE). "
06/01/2013 - "Variations at the ITGAM gene, which encodes for the CD11b chain of the Mac-1 (alphaMbeta2; CD11b/CD18; complement receptor-3) integrin, is one of the strongest genetic risk factors for systemic lupus erythematosus (SLE). "
10/01/2008 - "Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus."
01/06/2004 - "A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria."
01/01/2012 - "Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria."
06/01/2011 - "Further studies are needed to explore the pathophysiology of anaemia in malaria cases in Assam where expression of RBC complement receptors appears to be low even in normal healthy population."
07/01/2015 - "Severity of malaria in relation to a complement receptor 1 polymorphism: a case-control study."
03/01/2015 - "Although the polymorphisms of erythrocyte complement receptor type 1 (CR1) in patients with malaria have been extensively studied, a question of whether the polymorphisms of CR1 are associated with severe malaria remains controversial. "
09/01/1992 - "Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat."
01/01/2013 - "Wistar rats systemically pretreated with C1 INH (n = 6), APT070 (a membrane-targeted myristoylated peptidyl construct derived from human complement receptor 1, n = 4), vehicle (n = 7), or NaCl (n = 8) were subjected to 3h hind limb ischemia and 24h reperfusion. "
12/01/2004 - "Complement receptor 2-deficient (Cr2(-/-)) mice are resistant to mesenteric ischemia/reperfusion (I/R) injury because they lack a component of the natural Ab repertoire. "
02/01/1999 - "We examined the effect of soluble complement receptor type 1 (sCR1) on mucosal injury and inflammation in a rat model of ischemia/reperfusion. "
03/01/1994 - "Immunofluorescent studies demonstrated capping and clustering of PMN Fc and complement receptors during ischemia while adhered on matrix proteins. "
|1.||Complement System Proteins (Complement)
|2.||Antigen-Antibody Complex (Immune Complex)
|3.||cobra venom factor
|4.||Immunoglobulin G (IgG)
|5.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|8.||Complement C3b (C3bi)
|9.||Fc Receptors (Fc Receptor)
|1.||Heterologous Transplantation (Xenotransplantation)
|5.||Transplantation (Transplant Recipients)